Clinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2016 Sep 7

PMID 27598207

Citations 7

Authors

Jonathan A Pan

Michael Salerno

Affiliations

Soon will be listed here.

Abstract

Over the past several years, there have been major advances in cardiovascular positron emission tomography (PET) in combination with either computed tomography (CT) or, more recently, cardiovascular magnetic resonance (CMR). These multi-modality approaches have significant potential to leverage the strengths of each modality to improve the characterization of a variety of cardiovascular diseases and to predict clinical outcomes. This review will discuss current developments and potential future uses of PET/CT and PET/CMR for cardiovascular applications, which promise to add significant incremental benefits to the data provided by each modality alone.

Citing Articles

Automation of Copper-Mediated F-Fluorination of Aryl Pinacol Boronates Using 4-Dimethylaminopyridinium Triflate.

Nadporojskii M, Orlovskaya V, Fedorova O, Sysoev D, Krasikova R Molecules. 2024; 29(14).

PMID: 39064920 PMC: 11279627. DOI: 10.3390/molecules29143342.

The Role of Non-Invasive Multimodality Imaging in Chronic Coronary Syndrome: Anatomical and Functional Pathways.

Bergamaschi L, Pavon A, Angeli F, Tuttolomondo D, Belmonte M, Armillotta M Diagnostics (Basel). 2023; 13(12).

PMID: 37370978 PMC: 10297526. DOI: 10.3390/diagnostics13122083.

FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.

Lucinian Y, Martineau P, Poenaru R, Tremblay-Gravel M, Cadrin-Tourigny J, Harel F J Nucl Cardiol. 2023; 30(6):2490-2500.

PMID: 37258950 DOI: 10.1007/s12350-023-03306-3.

The Role of Positron Emission Tomography in Advancing the Understanding of the Pathogenesis of Heart and Vascular Diseases.

Blach A, Kwiecinski J Diagnostics (Basel). 2023; 13(10).

PMID: 37238275 PMC: 10217133. DOI: 10.3390/diagnostics13101791.

Role of Endomyocardial Biopsy in Diagnostics of Myocarditis.

Vidusa L, Kalejs O, Maca-Kaleja A, Strumfa I Diagnostics (Basel). 2022; 12(9).

PMID: 36140505 PMC: 9497694. DOI: 10.3390/diagnostics12092104.

References

Dorbala S, Hachamovitch R, Curillova Z, Thomas D, Vangala D, Kwong R . Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009; 2(7):846-54. PMC: 3954510. DOI: 10.1016/j.jcmg.2009.04.009. View

Taylor A, Salerno M, Dharmakumar R, Jerosch-Herold M . T1 Mapping: Basic Techniques and Clinical Applications. JACC Cardiovasc Imaging. 2016; 9(1):67-81. DOI: 10.1016/j.jcmg.2015.11.005. View

Sun M, Opavsky M, Stewart D, Rabinovitch M, Dawood F, Wen W . Temporal response and localization of integrins beta1 and beta3 in the heart after myocardial infarction: regulation by cytokines. Circulation. 2003; 107(7):1046-52. DOI: 10.1161/01.cir.0000051363.86009.3c. View

Schinkel A, Poldermans D, Elhendy A, Bax J . Assessment of myocardial viability in patients with heart failure. J Nucl Med. 2007; 48(7):1135-46. DOI: 10.2967/jnumed.106.038851. View

Delso G, Furst S, Jakoby B, Ladebeck R, Ganter C, Nekolla S . Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011; 52(12):1914-22. DOI: 10.2967/jnumed.111.092726. View

Capitanio S, Nanni C, Marini C, Bonfiglioli R, Martignani C, Dib B . Heterogeneous response of cardiac sympathetic function to cardiac resynchronization therapy in heart failure documented by 11[C]-hydroxy-ephedrine and PET/CT. Nucl Med Biol. 2015; 42(11):858-63. DOI: 10.1016/j.nucmedbio.2015.07.002. View

Shah P, Falk E, Badimon J, Fernandez-Ortiz A, Mailhac A, Fallon J . Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995; 92(6):1565-9. View

Ambrosio G, Betocchi S, Pace L, Losi M, Perrone-Filardi P, Soricelli A . Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease. Circulation. 1996; 94(10):2455-64. DOI: 10.1161/01.cir.94.10.2455. View

Morton G, Chiribiri A, Ishida M, Hussain S, Schuster A, Indermuehle A . Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography. J Am Coll Cardiol. 2012; 60(16):1546-55. PMC: 7611225. DOI: 10.1016/j.jacc.2012.05.052. View

10.

Gao H, Lang L, Guo N, Cao F, Quan Q, Hu S . PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2. Eur J Nucl Med Mol Imaging. 2012; 39(4):683-92. PMC: 3319105. DOI: 10.1007/s00259-011-2052-1. View

11.

Lertsburapa K, Ahlberg A, Bateman T, Katten D, Volker L, Cullom S . Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol. 2008; 15(6):745-53. DOI: 10.1007/BF03007355. View

12.

Di Carli M, Dorbala S, Meserve J, El Fakhri G, Sitek A, Moore S . Clinical myocardial perfusion PET/CT. J Nucl Med. 2007; 48(5):783-93. DOI: 10.2967/jnumed.106.032789. View

13.

Nensa F, Beiderwellen K, Heusch P, Wetter A . Clinical applications of PET/MRI: current status and future perspectives. Diagn Interv Radiol. 2014; 20(5):438-47. PMC: 4463332. DOI: 10.5152/dir.2014.14008. View

14.

Yen R, Chen Y, Wu Y, Pan M, Chang S . Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: a preliminary report. Acad Radiol. 2004; 11(3):316-21. DOI: 10.1016/s1076-6332(03)00715-3. View

15.

Hartmann F, Ziegler S, Nekolla S, Hadamitzky M, Seyfarth M, Richardt G . Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart. 1999; 81(3):262-70. PMC: 1728957. DOI: 10.1136/hrt.81.3.262. View

16.

Fukushima K, Javadi M, Higuchi T, Lautamaki R, Merrill J, Nekolla S . Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. J Nucl Med. 2011; 52(5):726-32. DOI: 10.2967/jnumed.110.081828. View

17.

Sherif H, Saraste A, Nekolla S, Weidl E, Reder S, Tapfer A . Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in rats. J Nucl Med. 2012; 53(2):318-23. DOI: 10.2967/jnumed.111.091652. View

18.

Salerno M, Kramer C . Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging. 2013; 6(7):806-22. PMC: 4073213. DOI: 10.1016/j.jcmg.2013.05.005. View

19.

Syed I, Glockner J, Feng D, Araoz P, Martinez M, Edwards W . Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2010; 3(2):155-64. DOI: 10.1016/j.jcmg.2009.09.023. View

20.

Danad I, Raijmakers P, Appelman Y, Harms H, de Haan S, van den Oever M . Coronary risk factors and myocardial blood flow in patients evaluated for coronary artery disease: a quantitative [15O]H2O PET/CT study. Eur J Nucl Med Mol Imaging. 2011; 39(1):102-12. PMC: 3227802. DOI: 10.1007/s00259-011-1956-0. View